Ocumension Therapeutics 13D and 13G filings for Alimera Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-04-30 1:16 pm Purchase | 2021-04-16 | 13G | Alimera Sciences, Inc. ALIM | Ocumension Therapeutics | 1,144,945 16.620% | 1,144,945 (New Position) | Filing |